IDWEEK 2016 – Pediatric Infectious Diseases

Extended-interval aminoglycoside dosing “appears of be safe in pediatric patients,” a retrospective study presented at IDWeek has found.

In children with cancer, concurrent vancomycin and piperacillin-tazobactam administration may increase risk of acute kidney injury, a retrospective study presented at IDWeek has shown.

Children presenting with outpatient influenza-like illness rarely received an antiviral prescription, according to a retrospective cohort study presented at IDWeek 2016.

Compared to multi-pill antiretroviral therapy (ART), 1-pill ART is associated with improved likelihoods of initial and sustained virologic suppression among HIV-positive young people, according to findings from a retrospective multiinstitutional analysis reported at IDWeek 2016.

Daptomycin was as effective as standard of care in treating Staphylococcus aureus bacteremia in children 1-17 years of age, according to study results reported at IDWeek 2016.

Children with perforated appendicitis had similar outcomes whether treated with antipseudomonal antibiotics or ceftriaxone plus metronidazole (CTX/MTZ), found authors of a retrospective cohort study reported at IDWeek.

For children hospitalized with severe flu, intravenous (IV) zanamivir may be the answer for those at high risk of complications who cannot tolerate enteral therapy, a study presented at IDWeek has found.